Sign Up to like & get
recommendations!
1
Published in 2020 at "American Journal of Ophthalmology Case Reports"
DOI: 10.1016/j.ajoc.2020.100615
Abstract: Purpose To describe a case of choroidal melanoma treated with Rigvir® virotherapy in an adjuvant setting. Observations A female patient born in 1956 presented with a small choroidal melanoma in October 2007. 34 months after…
read more here.
Keywords:
adjuvant setting;
virotherapy;
uveal melanoma;
case ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Melanoma Research"
DOI: 10.1097/cmr.0000000000000593
Abstract: Ipilimumab is approved for adjuvant melanoma treatment at a dose of 10 mg/kg, but its use is limited owing to high toxicity and treatment-associated costs. We retrospectively analyzed 29 patients who underwent complete resection of stage…
read more here.
Keywords:
adjuvant setting;
treatment;
ipilimumab;
melanoma ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Immunotherapy"
DOI: 10.2217/imt-2019-0087
Abstract: The use of immune checkpoint inhibitors has been approved in the advanced and metastatic setting for many types of solid tumors. Nonetheless, their role in the adjuvant setting is limited to the treatment of surgically…
read more here.
Keywords:
immune checkpoint;
solid tumors;
adjuvant setting;
use immune ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.971042
Abstract: COPYRIGHT © 2022 de Marinis, Attili, Gridelli, Cecere, Curcio, Facciolo and Spaggiari. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in…
read more here.
Keywords:
oncology;
incorporating atezolizumab;
adjuvant setting;
atezolizumab adjuvant ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Cancers"
DOI: 10.3390/cancers14122971
Abstract: Simple Summary The development of oncogene-targeted drugs has radically changed the course of non small cell lung carcinoma (NSCLC) in the advanced stage. Recently, the ADAURA trial demonstrated the efficacy of Osimertinib also in the…
read more here.
Keywords:
early stage;
adjuvant setting;
advanced stage;
stage ... See more keywords